Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease

Nalin H Dayawansa1,2,3, Sara Baratchi1,4,5, Karlheinz Peter1,2,3,5

  • 1Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Insights

Calcific aortic valve disease (CAVD) involves chronic inflammation and calcification. Mechanical stress and mechanosensing pathways drive disease progression, offering potential therapeutic targets for CAVD.

Area of Science:

  • Cardiovascular Biology
  • Biomedical Engineering
  • Pathophysiology

Background:

  • Calcific aortic valve disease (CAVD) is a prevalent valvulopathy with high mortality.
  • Chronic inflammation is the primary suspected driver of CAVD.
  • Current treatments do not halt CAVD progression.

Purpose of the Study:

  • To review inflammation and calcification pathways in CAVD.
  • To highlight the role of mechanical stress and mechanosensing in CAVD progression.
  • To explore mechanosensing pathways as potential therapeutic targets.

Main Methods:

  • Review of existing literature on CAVD pathophysiology.
  • Analysis of cellular and molecular mechanisms linking mechanical forces to valvular inflammation and calcification.
  • Examination of specific mechanosensitive pathways (RhoA/ROCK, YAP/TAZ, Piezo1, Notch).

Main Results:

  • Mechanical stress and mechanosensing are critical in perpetuating valvular inflammation and calcification in CAVD.
  • Mechanosensitive pathways convert mechanical forces into biochemical signals, creating a feedback loop that accelerates disease.
  • Specific pathways like RhoA/ROCK, YAP/TAZ, and Piezo1 are implicated in aortic valve mineralization and inflammation.

Conclusions:

  • Mechanosensing pathways provide crucial insights into CAVD pathogenesis.
  • Mechanotransduction of mechanical stress may link chronic inflammation and disease progression in CAVD.
  • Targeting mechanosensing pathways offers potential for novel therapeutic interventions and biomarkers for CAVD management.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
57
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
32
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
46
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
61
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
39
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
63